Dr. Ahmed AlWabari

Assistant Professor

Medical Oncology Consultant King Fahad Specialist Hospital- Dammam, Saudi Arabia

18 : 05 – 18 : 15

23 June | 2023 Day 1

SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC).

4th PSMMC ASCO Data Review Meeting (PADRM). This meeting will highlight the top most clinically relevant achievements of ASCO 2023 for different and commonest tumor types.